Vitality Watch

Dossier pubmed preclinical 16-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Quantitative proteomics reveals coordinated changes in the proteome during replicative senescence.

Key claim: Replicative senescence involves coordinated proteome remodeling—chromatin and translation-machinery depletion, mitochondrial protein insolubility, and compromised autophagy/proteasome activity—producing a distinctive proteostasis-shaped senescent signature.

Abstract

Cellular senescence is a state of irreversible cell cycle arrest triggered by telomere erosion, persistent DNA damage or chronic stress. The accumulation of senescent cells disrupts tissue function and contributes to aging and disease. Here, we employ mass spectrometry-based proteomics to systematically interrogate dynamic proteome changes at multiple levels during the progression of replicative cellular senescence. We demonstrate that proteome changes during senescence occur in a coordinated manner, characterized by widespread protein depletion on chromatin. Moreover, components of the cytoplasmic translation machinery are depleted, while mitochondrial proteins display increased insolubility. Autophagic and proteasome activity is compromised in senescent cells along with remodeling of ubiquitin linkages and depletion of ubiquitin E3 ligases. Comparison of the senescent proteome with different pathophysiological cellular states reveals a distinctive senescent signature shaped by changes in the proteostasis network. Collectively, we provide a resource for the exploration of temporally resolved changes in the senescent proteome.

Why this matters

Replicative senescence has largely been characterized by marker panels (p16, p21, SASP cytokines) and single-pathway readouts; a temporally resolved quantitative proteome instead frames senescence as a coordinated proteostasis collapse — chromatin and ribosome loss, mitochondrial aggregation, autophagy/proteasome insufficiency — that unifies mechanisms tracked on separate pages here. It supplies a resource-level substrate for interpreting future senomorphic/senolytic mechanism claims against a defined proteostatic baseline, but remains in vitro human fibroblast biology with no translational readout.

Source

Link

Briefing card

Quantitative proteomics reveals coordinated changes in the proteome during replicative senescence.
Stage: preclinical · pubmed · 16-sep-2026

Applies to researchers and companies pitching senolytic or senomorphic mechanisms — this resource defines a proteostasis-shaped senescent signature their candidates should be evaluated against, not a human outcome you can act on.

Replicative senescence involves coordinated proteome remodeling—chromatin and translation-machinery depletion, mitochondrial protein insolubility, and compromised autophagy/proteasome activity—producing a distinctive proteostasis-shaped senescent signature.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1038/s41467-026-77686-8

build build 880 · 2bcef25 · 2026-11-18